CCAP Stock Crescent Capital BDC (CCAP, $14.6) Moving Average Convergence Divergence (MACD) Histogram turned positive on August 12, 2025

GET DAILY SIGNALS

Get AI intraday signals

CCAP - Crescent Capital BDC

MACD signal

View

Odds of UP Trend

Price: $14.6

Daily change: +$0.25 (+1.74%)

Daily volume: 126K

Industry: Investment Managers

CCAP in upward trend: 10-day moving average crossed above 50-day moving average on August 14, 2025

The 10-day moving average for CCAP crossed bullishly above the 50-day moving average on August 14, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 12, 2025. You may want to consider a long position or call options on CCAP as a result. In of 79 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for CCAP just turned positive on August 12, 2025. Looking at past instances where CCAP's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .

CCAP moved above its 50-day moving average on August 08, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CCAP advanced for three days, in of 326 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 321 cases where CCAP Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 10 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CCAP declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

CCAP broke above its upper Bollinger Band on August 14, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.799) is normal, around the industry mean (7.287). P/E Ratio (13.126) is within average values for comparable stocks, (41.197). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.587). Dividend Yield (0.085) settles around the average of (0.076) among similar stocks. P/S Ratio (10.204) is also within normal values, averaging (14.058).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 71, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. CCAP’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.